Is capecitabine monotherapy efficient and safe in all line settings in patients with metastatic and advanced breast cancer?
Capecitabine monotherapy is effective and well tolerated in all line settings of chemotherapy in patients with metastatic or advanced breast cancer, and is suitable for outpatient therapy.
This study suggests a slight advantage for T over NP duration of the distal CMAP in the diagnosis of CIDP. However, the clinical relevance of this result must be weighed against the feasibility of this measurement.